We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+13.06%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$8.1B
AUM Growth
+$4.9B
Cap. Flow
+$4.22B
Cap. Flow %
52.11%
Top 10 Hldgs %
26.76%
Holding
6,444
New
505
Increased
3,426
Reduced
1,637
Closed
524

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$314M
2
AAPL icon
Apple
AAPL
+$247M
3
MSFT icon
Microsoft
MSFT
+$235M
4
AMZN icon
Amazon
AMZN
+$110M
5
NVDA icon
NVIDIA
NVDA
+$99M

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$21.7M
2
VNQ icon
Vanguard Real Estate ETF
VNQ
+$13.8M
3
SPLV icon
Invesco S&P 500 Low Volatility ETF
SPLV
+$12.8M
4
USO icon
United States Oil Fund
USO
+$12.5M
5
IBB icon
iShares Biotechnology ETF
IBB
+$12M

Sector Composition

Rank Sector Weight
1 Technology 26.14%
2 Financials 11.29%
3 Healthcare 10.69%
4 Consumer Discretionary 10.28%
5 Industrials 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QBTS.WS
5876
DELISTED
D-Wave Quantum Inc Warrants
QBTS.WS
$3 ﹤0.01%
38
-52
-58% -$4
SATLW icon
5877
Satellogic Inc Warrant
SATLW
$79M
$3 ﹤0.01%
41
– –
SOL
5878
DELISTED
Emeren Group
SOL
$3 ﹤0.01%
+1
New +$3
WBUY
5879
DELISTED
WEBUY GLOBAL LTD. Ordinary Shares
WBUY
$3 ﹤0.01%
+6
New +$22
ADVWW
5880
DELISTED
Advantage Solutions Warrant
ADVWW
$2 ﹤0.01%
23
– –
CLDI icon
5881
Calidi Biotherapeutics
CLDI
$3.96M
– –
0
– –
NRXPW
5882
DELISTED
NRX Pharmaceuticals Warrant
NRXPW
$2 ﹤0.01%
15
– –
SWVLW icon
5883
Swvl Holdings Corp Warrant
SWVLW
$2 ﹤0.01%
334
– –
UKOMW
5884
DELISTED
Ucommune International Ltd Warrant
UKOMW
$2 ﹤0.01%
206
– –
LSB
5885
DELISTED
LakeShore Biopharma
LSB
– –
-22
Closed -$127
CSCI
5886
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
– –
-26
Closed -$192
HIPO.WS
5887
DELISTED
Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share
HIPO.WS
$2 ﹤0.01%
124
– –
EFTRW
5888
DELISTED
eFFECTOR Therapeutics, Inc. Warrant
EFTRW
$2 ﹤0.01%
23
– –
FAZEW
5889
DELISTED
FaZe Holdings Inc. Warrant
FAZEW
$2 ﹤0.01%
363
– –
BENFW icon
5890
Beneficient Warrant
BENFW
$1 ﹤0.01%
77
– –
ECXWW
5891
ECARX Holdings Warrants
ECXWW
$1 ﹤0.01%
23
– –
HOFVW
5892
DELISTED
Hall of Fame Resort & Entertainment Company Warrant
HOFVW
$1 ﹤0.01%
100
– –
MLECW icon
5893
Moolec Science SA Warrant
MLECW
$1 ﹤0.01%
29
– –
SABSW icon
5894
SAB Biotherapeutics Warrant
SABSW
$104K
$1 ﹤0.01%
48
– –
SPRO icon
5895
Spero Therapeutics
SPRO
$73M
$1 ﹤0.01%
1
-571
-100% -$681
WGSWW
5896
DELISTED
GeneDx Holdings Warrant
WGSWW
$1 ﹤0.01%
128
– –
PDYNW icon
5897
Palladyne AI Corp Warrants
PDYNW
$156K
$1 ﹤0.01%
269
– –
MKFG.WS
5898
DELISTED
Markforged Holding Corporation Warrants, each whole warrant exercisable to purchase one-tenth (1/10th) of a share of Common Stock at an exercise price of $115.00 per share
MKFG.WS
$1 ﹤0.01%
20
– –
VLD.WS
5899
DELISTED
Velo3D, Inc. Redeemable warrants, each Warrant exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50
VLD.WS
$1 ﹤0.01%
17
– –
JTAIW
5900
DELISTED
Jet.AI Inc. Warrant
JTAIW
$1 ﹤0.01%
29
– –
234 235
236
237 238

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2023 Portfolio in Review

As of Q4 2023, Tower Research Capital (TRC) held 6,444 positions worth $8.1B, up 153% from $3.2B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $4.22B of net new capital in Q4 2023, opening 505 new positions and adding to 3,426 existing holdings. Its largest new stake was Veralto: 28,523 shares worth $2.35M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $21.7M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2023 buy was Veralto: 28,523 shares worth $2.35M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $314M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2023 reduction was iShares MSCI EAFE ETF, cutting an estimated $21.7M.
  • Tower Research Capital (TRC) fully exited Vanguard Morningstar Total Stock Market ETF in Q4 2023, selling an estimated $6.02M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $8.1B portfolio in Q4 2023.
  • Tower Research Capital (TRC) opened 505 new positions and closed 524 in Q4 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 153% quarter-over-quarter to $8.1B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.